Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Rationalizing Drug Cocktails: NPPA to conduct prescription audit of FDC drugs

Farhat Nasim12 Feb 2021 11:06 AM IST

New Delhi: In order to keep a strict vigil on fixed-dose combination (FDC) drugs in India, the National Pharmaceuticals Pricing Authority (NPPA) has...

All Escitalopram formulations to carry boxed warning: CDSCO tells 102 pharma firms

Farhat Nasim5 Feb 2021 3:28 PM IST

New Delhi: Through a recent notification, the Central Drugs Standard Control Organization (CDSCO) has directed all the manufacturers of Escitalopram...

COVAXIN debate: Minister replies on why Bharat Biotech was granted approval for emergency use

Farhat Nasim3 Feb 2021 7:06 PM IST

New Delhi: The Covid-19 vaccine, Covaxin, developed by Bharat Biotech has the potential to target mutated coronavirus strains. Further, the data...

Zydus erectile dysfunction drug Avanafil to be sold only on Cardiologists, Psychiatrists, Urologists prescription: CDSCO panel

Farhat Nasim1 Feb 2021 6:39 PM IST

New Delhi: Noting that Avanafil Tablets should be sold by retail on the prescription of Cardiologists, Psychiatrists and Urologists only, the...

Drug majors including Cipla, Sun Pharma, Pfizer, others owe Rs 6,550 crore overcharged amount : NPPA

Farhat Nasim29 Jan 2021 6:44 PM IST

New Delhi: Several drug majors including Cipla, Ranbaxy, Lupin, Glenmark, Sun Pharma have been accused of overcharging consumers to the tune of...

More than 2.84 lakh vaccinated so far: Karnataka Health Minister

Farhat Nasim29 Jan 2021 9:15 AM IST

Bengaluru: Karnataka has vaccinated over 2.84 lakh people since the launch of the vaccination drive on January 16, state Health Minister Dr K Sudhakar...

Dr Reddys, Zuventus get CDSCO panel okay to conduct Covid-19 trials on Aviptadil

Farhat Nasim27 Jan 2021 6:26 PM IST

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted permission to Dr...

Delhi to have integrated hospital management system by 2021

Farhat Nasim26 Jan 2021 9:45 AM IST

The chief minister said the Health Information Management System (HIMS) will be completed this year with the integration of government hospitals...

COVID-19 vaccination sites increased to 510 in Gujarat

Farhat Nasim26 Jan 2021 9:15 AM IST

"This number may increase further as local civic bodies were given the freedom to add more sites as per their convenience," said Jani.

India records 131 more COVID-19 deaths, 13,203 cases: Health Ministry

Farhat Nasim26 Jan 2021 9:00 AM IST

The Health Ministry stressed that more than 70 percent of the deaths occurred due to comorbidities.

Between 2 to 3.5 percent of people developed side-effects from Covid-19 jab: Health Minister K Sudhakar

Farhat Nasim24 Jan 2021 9:30 AM IST

Bengaluru: As many as 1.39 lakh people have been inoculated in Karnataka and some did have side-effects but there was no casualty, state Health...

Massive Fire at Serum Institute Pune plant; 5 dead

Farhat Nasim21 Jan 2021 6:35 PM IST

Pune: A massive fire broke out at the Pune-based Serum Institute of India's (SII) building on Thursday afternoon resulting in the death of five...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok